PPD and ePharmaSolutions Win 2013 Microsoft Life Sciences Innovation Award

Strategic alliance delivering integrated, portal-based collaboration tools to streamline clinical trial management and study start-up for biopharmaceutical clients.

Pharmaceutical Product Development, LLC (PPD) and ePharmaSolutions today announced that their strategic alliance has been recognized with a Microsoft 2013 Life Sciences Innovation Award, honoring their initiatives in integrating world-leading clinical research expertise and eClinical solutions to advance biopharmaceutical clients’ research programs.

Through PPD’s alliance with ePharmaSolutions, a leading clinical services and eClinical solutions provider, PPD clients and investigative sites benefit from innovative new enterprise tools that enable faster and easier site feasibility and study start-up, study training, site management, and patient recruitment and engagement.

Microsoft recognized ePharmaSolutions’ PatientLive™ and PPD® PatientView, two online portal applications that provide access to the Microsoft HealthVault™ personal health record solution. PPD and ePharmaSolutions’ collaboration covers a suite of innovative portal technologies, also including:

* PPD® SponsorView, providing PPD clients easy online access to trial-related documents, key reports, metrics and other vital information.
* PPD® SiteView, enhancing connectivity among research sites, PPD and sponsors and featuring regulatory document collection with training, contact information and site closeout details, along with central access to other key systems, such as electronic data capture.

Microsoft honored PPD and ePharmaSolutions June 25 in Boston at the 49th annual meeting of the Drug Information Association (DIA). The Microsoft Life Sciences Innovation Awards recognize companies using Microsoft solutions to realize business and information technology benefits and revolutionize medicine by bringing therapeutic breakthroughs to the market faster to fight serious ailments, improve health care and enhance patients’ quality of life.

ePharmaSolutions’ PatientLive™ matches patients to clinical trials using a geo-therapeutic matching algorithm and opt-in intelligent profiles to alert patients about trials for which they may qualify to improve patient engagement and the opportunity to participate in a trial. PPD PatientView links clinical trial participants with clinical research sites, biopharmaceutical companies, physicians and health care resources to enhance patient connectivity and improve patient retention in trials.

“This recognition demonstrates the value of our strategic relationship with ePharmaSolutions and the time and cost efficiencies our clients gain in conducting clinical trials,” said Mike Wilkinson, PPD’s chief information officer and executive vice president. “Our collaboration leverages PPD’s people, processes and technologies to help investigative sites and biopharmaceutical companies streamline their R&D programs in a fast-evolving clinical research environment.”

Lance Converse, founder and chief executive officer of ePharmaSolutions, said: “PPD is an innovative organization looking to meet the needs of its clients. Our integrated platform enables easy-to-use collaboration capabilities, secure document exchange and learning management as a core component of PPD’s enterprise environment designed for process efficiency, compliance and reliability.”